Claus Høgdall

Professor in Clinical Gynecologic Oncology

University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Claus Høgdall is a Professor in Clinical Gynecologic Oncology at the University of Copenhagen, Denmark. His research focuses on ovarian cancer, including clinical characteristics, prognostic factors, and novel diagnostic methodologies. Recent articles highlight his work on homologous recombination deficiency status, CA-125 levels in low-grade serous ovarian cancer, and the potential of organoids in personalized treatment decisions.

Articles (12)

Year:

2025

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Weiva Sieh

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Claus Høgdall

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Clinical Characteristics and Survival of Ovarian Cancer Patients According to Homologous Recombination Deficiency Status

Proof of Concept Study: Comparison of Semi-Automated RNA Isolation Methods from Archived Formalin-Fixed, Paraffin-Embedded Tissues with Clinical Routine RNA Isolation Methods

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment.

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer&mdash;A Multicenter Analysis

Prospects of Improving Early Ovarian Cancer Diagnosis Using Cervical Cell Swabs.

Assessment of recurrence rate and risk factors of relapse in stage in IA vulvar carcinoma.

Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review).

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures.

Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study.

Collaborators (17)

Weiva Sieh

Niclas Håkansson

Marco Montagna

Gordana Popovic

Sergio Ruiz-Llorente

P. M. Webb

Carien Creutzberg

Estrid V. Hoegdall

Susanne Kjaer

Allison DePersia

Eileen Dareng

Line Bjørge

Katrine Fuglsang

Liv Thomsen

Håkan Olsson

Zdenek Kleibl

Tine Henrichsen Schnack

Make your next move.

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis